Authors: Moczulski, DK Grzeszczak, W Gawlik, B

Citation: Dk. Moczulski et al., Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy, DIABET CARE, 24(7), 2001, pp. 1187-1191

Authors: Grzeszczak, W Moczulski, DK Zychma, M Zukowska-Szczechowska, E Trautsolt, W Szydlowska, I

Citation: W. Grzeszczak et al., Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes, KIDNEY INT, 59(2), 2001, pp. 631-636

Authors: Moczulski, DK Scott, L Antonellis, A Rogus, JJ Rich, SS Warram, JH Krolewski, AS

Citation: Dk. Moczulski et al., Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus, DIABET MED, 17(2), 2000, pp. 111-118

Authors: Zanchi, A Moczulski, DK Hanna, LS Wantman, M Warram, JH Krolewski, AS

Citation: A. Zanchi et al., Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism, KIDNEY INT, 57(2), 2000, pp. 405-413

Authors: Araki, S Moczulski, DK Hanna, L Scott, LJ Warram, JH Krolewski, AS

Citation: S. Araki et al., APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes - Results of case-control and family-based studies, DIABETES, 49(12), 2000, pp. 2190-2195

Authors: Moczulski, DK Burak, W Doria, A Zychma, M Zukowska-Szczechowska, E Warram, JH Grzeszczak, W

Citation: Dk. Moczulski et al., The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus, DIABETOLOG, 42(1), 1999, pp. 94-97